Michal Kyr

Brno, JM 62500, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Individualized therapeutic approaches for relapsed and refractory pediatric ependymomas: a single institution experience.

Individualized therapeutic approaches for relapsed and refractory pediatric ependymomas: a single institution experience.

Journal: Journal of neuro-oncology

Published: January 29, 2025

Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits.

Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: November 24, 2024

Real-World Performance of Integrative Clinical Genomics in Pediatric Precision Oncology.

Real-World Performance of Integrative Clinical Genomics in Pediatric Precision Oncology.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: June 26, 2024

Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome.

Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome.

Journal: NPJ precision oncology

Published: October 20, 2023

Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patients.

Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patients.

Journal: International journal of cancer

Published: August 06, 2023

Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing.

Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing.

Journal: JCO precision oncology

Published: June 14, 2022

N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine-A Review.

N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine-A Review.

Journal: Cancers

Published: September 01, 2021

Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy - Observational prospective single institution analysis.

Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy - Observational prospective single institution analysis.

Journal: Journal of bone oncology

Published: December 09, 2020

Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize.

Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize.

Journal: Frontiers in oncology

Published: January 20, 2020

Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision?

Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision?

Journal: Cancers

Published: December 25, 2019

Granulation tissue enriched by aspirin and omega-3 fatty acids in healing experimental periodontal lesion.

Granulation tissue enriched by aspirin and omega-3 fatty acids in healing experimental periodontal lesion.

Journal: Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia

Published: November 03, 2019

Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside.

Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside.

Journal: Frontiers in oncology

Published: July 18, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026